Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01691820 · ClinicalTrials.gov registry record · NA
A Study in Adolescent Females to Explore Cytomegalovirus Infection
A NA study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- NA
- Development phase
- 369
- Enrollment target
NCT01691820 is a NA study that has completed, run by GlaxoSmithKline. The registered enrollment target is 369 participants.
The verdict
NCT01691820, a NA study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- NA
- Development phase
- 369 participants
- Enrollment target
Study Summary
The purpose of this study is to estimate the incidence of Cytomegalovirus (CMV) secondary infections (re-infections/re-activations) and the incidence of CMV primary infections in adolescent females.
Interventions
- PROCEDURE Blood collection
- PROCEDURE Urine collection
- PROCEDURE Saliva collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 369 participants |
| Start Date | 2012-10-05 |
| Est. Completion | 2017-04-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01691820
The ClinicalTrials.gov registry entry for NCT01691820 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 369 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Blood collection is the first listed.
NCT01691820 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01691820 about?
NCT01691820 is a clinical study titled "A Study in Adolescent Females to Explore Cytomegalovirus Infection". The purpose of this study is to estimate the incidence of Cytomegalovirus (CMV) secondary infections (re-infections/re-activations) and the incidence of CMV primary infections in adolescent females.
What is the current status of trial NCT01691820?
This trial is currently completed. It is a NA study. The enrollment target is 369 participants. The study started on 2012-10-05. Estimated completion is 2017-04-08.
What interventions are being tested in trial NCT01691820?
The interventions under investigation include: Blood collection (PROCEDURE), Urine collection (PROCEDURE), Saliva collection (PROCEDURE).
Who is sponsoring clinical trial NCT01691820?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.